omega-n-methylarginine has been researched along with bradykinin in 142 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.41) | 18.7374 |
| 1990's | 89 (62.68) | 18.2507 |
| 2000's | 45 (31.69) | 29.6817 |
| 2010's | 6 (4.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goy, MF; McGehee, DS; Oxford, GS | 1 |
| Cocks, T; Crack, P | 1 |
| D'Orleans-Juste, P; Hecker, M; Mitchell, JA; Vane, JR; Wood, EG | 1 |
| Harasawa, Y; Hayashi, S; Kimura, M; Maeda, K; Nakamura, M; Ohno, Y; Sakurai, I | 1 |
| Mayhan, WG | 2 |
| Bohlen, HG; Lash, JM | 1 |
| Kaley, G; Koller, A; Messina, EJ; Rodenburg, JM; Wolin, MS | 1 |
| Newman, CM; O'Shaughnessy, KM; Warren, JB | 1 |
| Förstermann, U; Ishii, K; Murad, F; Sheng, H; Warner, TD | 1 |
| Cohen, RA; Cowan, CL | 1 |
| Chester, AH; Moncada, S; O'Neil, GS; Tadjkarimi, S; Yacoub, MH | 1 |
| Förster, S; Schrör, K; Woditsch, I | 1 |
| de Graeff, PA; de Leeuw, MJ; Scholtens, E; van Gilst, WH; Wesseling, H | 1 |
| Gavras, H; Gavras, I; Lammek, B; Wang, YX; Wierzba, T | 1 |
| Bosnjak, ZJ; Flynn, NM; Kampine, JP; Kenny, D; Pelc, LR; Warltier, DC | 1 |
| Cicala, C; Cirino, G; Regoli, D; Sorrentino, L | 1 |
| Davidson, D; Eldemerdash, A | 1 |
| Chapnick, BM; Pawloski, JR | 1 |
| Fiksen-Olsen, MJ; Lahera, V; Romero, JC; Salom, MG | 1 |
| Nakamura, T; Prewitt, RL | 1 |
| Greenberg, SS; Peevy, K; Tanaka, TP | 1 |
| Bolden, C; Johnson, A; McKinney, M; Richelson, E; Smith, C | 1 |
| Byrns, RE; Fukuto, J; Gold, ME; Ignarro, LJ; Wood, KS | 1 |
| Johns, RA; Linden, J; Peach, MJ; Tichotsky, A | 1 |
| Boulanger, C; Moncada, S; Schini, VB; Vanhoutte, PM | 1 |
| Lopez-Belmonte, J; Rees, DD; Whittle, BJ | 1 |
| Archer, SL; Raij, L; Tolins, JP; Weir, EK | 1 |
| Lewis, MJ; Siney, L | 1 |
| Burgess, GM; Harvey, JS | 1 |
| Bedarida, GV; Blaschke, TF; Hoffman, BB; Kim, D | 1 |
| Dai, HB; Piana, RN; Sellke, FW; Shafique, T | 1 |
| Brett, SE; Chowienczyk, PJ; Cockcroft, JR; Ritter, JM | 1 |
| Barclay, JK; Woodley, NE | 1 |
| Currie, MG; Masferrer, JL; Misko, TP; Needleman, P; Salvemini, D; Seibert, K; Settle, SL | 1 |
| Berkenboom, G; Brékine, D; Fontaine, J; Grosfils, K; Staroukine, M; Unger, P | 1 |
| Bhagat, K; MacAllister, R; Malinski, T; Moncada, S; Patton, S; Radomski, M; Vallance, P | 1 |
| Jain, B; Leise, KL; Robbins, RA; Rubinstein, I; Sisson, JH | 1 |
| Cai, B; Greenberg, SS; Kolls, J; Lippton, H; Nelson, S; Summer, WR; Wang, Y; Xie, J | 1 |
| Collier, JG; O'Kane, KP; Vallance, PJ; Webb, DJ | 1 |
| Cannon, RO; García, CE; Kilcoyne, CM; Panza, JA; Quyyumi, AA | 1 |
| Geppetti, P; Nadel, JA; Ricciardolo, FL; Yoishihara, S; Yoshihara, S | 1 |
| Bauer, MB; Gebhart, GF; Murphy, S; Simmons, ML | 1 |
| Calixto, JB; Schlemper, V | 1 |
| Cannon, RO; García, CE; Gilligan, DM; Guetta, V; Panza, JA; Quyyumi, AA | 1 |
| Fukazawa, M; Namiki, A | 1 |
| Coceani, F; Wang, Y | 1 |
| MacDermot, J; McEwan, JR; Parsaee, H | 1 |
| Baker, CH; Price, JM; Sutton, ET; Zhou, Z | 1 |
| Greenberg, SS; Summer, WR; Wang, Y; Xie, J | 1 |
| Fujikura, H; Hasegawa, Y; Ishii, Y; Sekiguchi, N; Takayanagi, I | 1 |
| Mundin, JW; Sumner, MJ; Watts, IS; White, DG | 1 |
| Green, PG; Heller, PH; Levine, JD; Luo, J | 1 |
| Förstermann, U; Ishii, K; Murad, F; Sheng, H | 1 |
| Aoyama, T; Iimura, O; Iwata, M; Nomura, N; Shimamoto, K; Takagawa, Y; Ura, N | 1 |
| Ando, J; Inukai, M; Kato, M; Kawaguchi, H; Korenaga, R; Miyamoto, M; Sakamoto, A; Shimamoto, N; Shin, WS; Toyo-oka, T; Uehara, Y; Wang, Y | 1 |
| Emanueli, C; Figini, M; Folkerts, G; Geppetti, P; Javdan, P; Nijkamp, FP; Pradelles, P; Ricciardolo, FL | 1 |
| Bellofiore, S; Di Maria, GU; Geppetti, P; Mistretta, A; Nadel, JA; Ricciardolo, FL; Sapienza, MA | 1 |
| Kondo, M; Konno, K; Sakai, A; Tamaoki, J | 1 |
| Kishimoto, T; Ohno, M; Tada, M | 1 |
| Baskin, SI; Lempka, JC; Nealley, EW | 1 |
| Dear, JW; Foreman, JC; Ghali, S | 1 |
| Anzai, M; Shibuya, M; Suzuki, Y; Takayasu, M; Tanazawa, T; Tsugane, S | 1 |
| Arndt, JO; Kindgen-Milles, D | 1 |
| Az-ma, T; Fujii, K; Yuge, O | 1 |
| Cachofeiro, V; Casal, MC; Lahera, V; Maeso, R; Munoz-Garcia, R; Navarro, J; Rodrigo, E; Ruilope, LM | 1 |
| Jaffa, AA; Margolius, HS; Siragy, HM | 1 |
| Egashira, K; Hirakawa, Y; Kuga, T; Mohri, M; Shimokawa, H; Tagawa, T; Takeshita, A | 1 |
| Béa, ML; Berdeaux, A; Beverelli, F; Giudicelli, JF; Puybasset, L | 1 |
| Di Maria, GU; Geppetti, P; Mistretta, A; Ricciardolo, FL; Sapienza, MA | 1 |
| Barber, DA; Miller, VM | 1 |
| Kajiyama, G; Kato, M; Matsuura, H; Shiode, N; Yamagata, T | 1 |
| Black, PN; Brodie, SM | 1 |
| Evora, PR; Pearson, PJ; Schaff, HV; Seccombe, JF | 1 |
| LaPointe, MC; Marsh, JD; Ritchie, RH; Schiebinger, RJ | 1 |
| Atwood, L; James, C; Morris, GP; Vanner, S | 1 |
| Ballejo, G; Resende, AC; Salgado, MC | 1 |
| Di Maria, GU; Fabbri, LM; Geppetti, P; Rado, V; Ricciardolo, FL; Sterk, PJ | 1 |
| Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
| Brown, GC; Clementi, E; Foxwell, N; Moncada, S | 1 |
| Homma, T; Irvin, CG | 1 |
| Blaschke, TF; Chalon, S; Hoffman, BB; Moreno, H; Tejura, B; Urae, A | 1 |
| Blaschke, TF; Chalon, S; Hoffman, BB; Moreno, H | 1 |
| Bateson, EA; Olley, PM; Schulz, R | 1 |
| Barba, G; Donald, A; MacAllister, RJ; Mullen, MJ | 1 |
| Hirao, H; Kajiyama, G; Kato, M; Matsuura, H; Shiode, N; Teragawa, H; Yamada, T; Yamagata, T | 1 |
| Bhagat, K; Charles, IG; Hingorani, AD; Palacios, M; Vallance, P | 1 |
| Ashworth, JR; Baker, PN; Johnson, IR; Warren, AY | 1 |
| Buralli, S; Ghiadoni, L; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Baldassarre, S; Berkenboom, G; Fontaine, D; Fontaine, J; Preumont, N; Unger, P | 1 |
| Burnett, JC; Miller, VM; Rabelink, T; Wennberg, PW | 1 |
| Chang, YS; Dull, RO; Gardner, TW; Hillsley, MV; Jain, RK; Lakshminarayanan, S; Munn, LL; Tarbell, JM; Yuan, J | 1 |
| MacCarthy, PA; Shah, AM | 1 |
| Chen, J; Choi, DK; Hikiji, H; Iwasawa, K; Nakajima, T; Sakaki, Y; Sunamoto, M; Toyo-Oka, T; Wang, Y; Yoshida, Y | 1 |
| Honing, ML; Morrison, PJ; Rabelink, TJ; Smits, P | 1 |
| Chilian, WM; Nishikawa, Y; Stepp, DW | 1 |
| Amado, JA; Ceballos, C; de Berrazueta, JR; García Unzueta, MT; Pérez, J; Ribes, C | 1 |
| Harada, Y; Hayashida, Y; Ikeda, M; Murasato, Y; Nanri, H; Suzuka, H | 1 |
| Foreman, JC; Maggs, JR; Turner, PJ | 1 |
| Adnot, S; Belhassen, L; Benacerraf, S; Carville, C; Dubois-Randé, JL; Sediame, S | 1 |
| Brown, NJ; Gainer, JV; Murphey, LJ; Vaughan, DE | 1 |
| Epstein, N; Husain, S; Mincemoyer, R; Prasad, A; Quyyumi, AA; Schenke, W | 1 |
| Gute, DC; Ishida, S; Korthuis, RJ; Shigematsu, S | 1 |
| Decking, UK; Flögel, U; Godecke, A; Merx, MW; Schrader, J | 1 |
| Isoda, T; Kass, DA; Pagliaro, P; Paolocci, N; Saavedra, FW | 1 |
| Mahdi, F; Qiu, Q; Røjkjaer, R; Schmaier, AH; Shariat-Madar, Z; Zhao, Y | 1 |
| Campagnola, M; Cominacini, L; Davoli, A; Garbin, U; Lo Cascio, V; Pasini, AF; Pastorino, AM; Rigoni, A; Sawamura, T | 1 |
| Cramer-Joyce, L; Halcox, JP; Mincemoyer, R; Narayanan, S; Quyyumi, AA | 1 |
| Chan, NN; Colhoun, HM; Hingorani, AD; MacAllister, RJ; Vallance, P | 1 |
| Brahim, JJ; de Gouw, HW; Geppetti, P; Hiemstra, PS; Ricciardolo, FL; Sont, JK; Sterk, PJ; Timmers, MC; van Krieken, JH; van Schadewijk, A | 1 |
| Jaimes, EA; Raij, L; Sweeney, C | 1 |
| Longhurst, JC; Phan, NT; Tjen-A-Looi, SC | 1 |
| Brosnihan, KB; Ishii, M; Masumori-Maemoto, S; Ueda, S; Umemura, S; Wada, A | 1 |
| Ding, Z; Gödecke, A; Schrader, J; Ziegler, M | 1 |
| Chan, NN; Colhoun, HM; Conway, GS; Hingorani, AD; MacAllister, RJ; Vallance, P | 1 |
| Decking, UK; Flogel, U; Kojic, ZZ; Schrader, J | 1 |
| Drexler, H; Hornig, B; Kohler, C; Schlink, D; Tatge, H | 1 |
| Fexby, S; Hughes, AD; Regan, L; Thom, SA; Wimalasundera, R | 1 |
| Chan, NN; Colhoun, HM; Vallance, P | 1 |
| Chacur, M; Cury, Y; Guerra, JL; Gutiérrez, JM; Lomonte, B; Longo, I; Picolo, G; Teixeira, CF | 1 |
| Burke, V; Croft, KD; Playford, DA; Watts, GF | 1 |
| Fujita, N; Manabe, H; Matsumoto, N; Naito, Y; Ochiai, J; Oka, S; Takagi, T; Uemura, M; Yoshida, N; Yoshikawa, T | 1 |
| Büssemaker, E; Fauler, J; Fleming, I; Gross, P; Lässig, G; Passauer, J; Pistrosch, F | 1 |
| Chan, NN; Colhoun, HM; Fuller, JH; Rubens, M | 1 |
| Folkerts, G; Ricciardolo, FL; Sont, JK; Sterk, PJ; Timmers, MC | 1 |
| Feng, GG; Hotta, Y; Ishikawa, A; Ishikawa, N; Kurimoto, N; Nan, YS; Nishiwaki, K; Shigei, T; Shimada, Y | 1 |
| Alexeyev, MF; Cohen, MV; Downey, JM; Krieg, T; Philipp, S; Qin, Q | 1 |
| Clapp, BR; Hingorani, AD; Kharbanda, RK; MacAllister, RJ; Mohamed-Ali, V; Stephens, JW; Vallance, P | 1 |
| Chowienczyk, PJ; Dwivedi, R; Ritter, JM; Saha, S | 1 |
| Ikeoka, K; Koida, S; Ohyanagi, M; Takahashi, K; Ueda, A | 1 |
| Barton, CH; Ding, Y; Ni, Z; Vaziri, ND | 1 |
| Cipriano, A; Franzoni, F; Galetta, F; Ghiadoni, L; Magagna, A; Salvetti, A; Taddei, S; Versari, D; Virdis, A | 1 |
| Martin, W; Overend, J | 1 |
| Adner, M; Cardell, LO; Zhang, Y | 1 |
| De Negri, F; Duranti, E; Giannarelli, C; Magagna, A; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Brown, NJ; Pretorius, M | 1 |
| Agabiti Rosei, E; Boari, GE; de Ciuceis, C; Favero, G; Foglio, E; Paiardi, S; Platto, C; Porteri, E; Rezzani, R; Rizzardi, N; Rizzoni, D; Rodella, LF | 1 |
| Brown, NJ; Fong, P; Pretorius, M; Stafforini, DM | 1 |
| Kavtaradze, N; Lin, J; Manatunga, A; Murrow, JR; Ozkor, MA; Quyyumi, AA; Rahman, AM | 1 |
| Brouwers, S; Dupont, AG; Massie, A; Smolders, I | 1 |
| Hayek, S; Kavtaradze, N; Lin, J; Manatunga, A; Murrow, JR; Ozkor, MA; Quyyumi, AA; Rahman, AM | 1 |
| De Staercke, C; Hayek, S; Hooper, WC; Kavtaradze, N; Lin, J; Manatunga, A; Murrow, JR; Ozkor, MA; Quyyumi, AA; Rahman, AM | 1 |
1 review(s) available for omega-n-methylarginine and bradykinin
| Article | Year |
|---|---|
Role of non-nitric oxide non-prostaglandin endothelium-derived relaxing factor(s) in bradykinin vasodilation.
Topics: Animals; Bradykinin; Cannabinoid Receptor Modulators; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Hypotension; Nitric Acid; Nitric Oxide; omega-N-Methylarginine; Potassium Channels; Prostaglandins; Vasodilation; Vasomotor System | 1998 |
19 trial(s) available for omega-n-methylarginine and bradykinin
| Article | Year |
|---|---|
Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Bradykinin; Captopril; Coronary Circulation; Cysteine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Nitro Compounds; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Vasodilator Agents | 1991 |
Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm.
Topics: Adult; Analysis of Variance; Arginine; Brachial Artery; Bradykinin; Drug Interactions; Endothelium, Vascular; Forearm; Humans; Infusions, Intra-Arterial; Male; Nitric Oxide; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Substance P; Vasodilation | 1994 |
Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm.
Topics: Adult; Arginine; Bradykinin; Dose-Response Relationship, Drug; Forearm; Humans; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Norepinephrine; omega-N-Methylarginine; Regional Blood Flow; Vasodilation | 1994 |
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Topics: Acetylcholine; Adult; Arginine; Arm; Bradykinin; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Signal Transduction; Vascular Resistance; Vasodilation | 1995 |
Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma.
Topics: Adult; Aerosols; Arginine; Asthma; Bradykinin; Bronchial Provocation Tests; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lung Volume Measurements; Male; Methacholine Chloride; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine | 1996 |
Impairment of bronchoprotection by nitric oxide in severe asthma.
Topics: Adult; Asthma; Bradykinin; Bronchoconstriction; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 1997 |
Nitric oxide and response to inhaled bradykinin in severe asthma.
Topics: Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Bradykinin; Bronchial Provocation Tests; Case-Control Studies; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 1998 |
Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins.
Topics: Adult; Bradykinin; Enzyme Inhibitors; Female; Hand; Humans; Isoproterenol; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Time Factors; Vasoconstriction; Vasodilation; Veins | 1999 |
Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Bronchial Hyperreactivity; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Humans; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Receptor, Bradykinin B2 | 2000 |
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Adrenergic beta-Antagonists; Adult; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Forearm; Humans; Indomethacin; Infusions, Intra-Arterial; Male; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Receptor, Bradykinin B2; Regional Blood Flow; Tissue Plasminogen Activator; Vasodilation; Vasodilator Agents | 2000 |
Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation.
Topics: Administration, Oral; Adult; Aspirin; Biological Factors; Blood Flow Velocity; Brachial Artery; Bradykinin; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Forearm; Humans; Infusions, Intra-Arterial; Miconazole; Microcirculation; Middle Aged; Nitroprusside; omega-N-Methylarginine; Phenylephrine; Plethysmography; Potassium Chloride; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System | 2001 |
Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.
Topics: Adult; Angiotensin I; Angiotensin II; Bradykinin; Cross-Over Studies; Double-Blind Method; Drug Synergism; Enzyme Inhibitors; Humans; Male; omega-N-Methylarginine; Peptide Fragments; Reference Values; Vasoconstrictor Agents; Vasodilation | 2001 |
AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Bradykinin; Bradykinin Receptor Antagonists; Coronary Artery Disease; Endothelium, Vascular; Enzyme Inhibitors; Humans; Infusions, Intra-Arterial; Middle Aged; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Radial Artery; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrazoles | 2003 |
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes.
Topics: Acetylcholine; Antioxidants; Apolipoprotein A-I; Area Under Curve; Blood Circulation; Blood Pressure; Bradykinin; Cholesterol, HDL; Cholesterol, LDL; Coenzymes; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; F2-Isoprostanes; Female; Fenofibrate; Forearm; Glycated Hemoglobin; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Statistics as Topic; Systole; Treatment Outcome; Triglycerides; Ubiquinone; Vasodilator Agents | 2003 |
Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.
Topics: Adult; Analysis of Variance; Aryl Hydrocarbon Hydroxylases; Bradykinin; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Forearm; Humans; Ibuprofen; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Sulfaphenazole; Vasodilator Agents | 2003 |
Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma.
Topics: Administration, Inhalation; Adult; Allergens; Area Under Curve; Asthma; Bradykinin; Cross-Over Studies; Female; Forced Expiratory Volume; Humans; Male; Nitric Oxide; omega-N-Methylarginine | 2003 |
Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress.
Topics: Adult; Albuminuria; Analysis of Variance; Arginine; Ascorbic Acid; Biological Availability; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Forearm; Humans; Male; Nitric Oxide; Nitroglycerin; Norepinephrine; omega-N-Methylarginine; Oxidative Stress; Plethysmography; Regional Blood Flow; Statistics, Nonparametric; Typhoid-Paratyphoid Vaccines; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease.
Topics: Acetylcholine; Adult; Biological Factors; Bradykinin; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Plethysmography; Potassium Channel Blockers; Potassium Channels; Regional Blood Flow; Risk Factors; Tetraethylammonium; Vasodilation; Young Adult | 2011 |
Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.
Topics: Adult; Biological Factors; Bradykinin; Cytochrome P-450 Enzyme System; Female; Fluconazole; Forearm; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Potassium Channels, Calcium-Activated; Regional Blood Flow; Tetraethylammonium; Tissue Plasminogen Activator; Vasodilation | 2014 |
122 other study(ies) available for omega-n-methylarginine and bradykinin
| Article | Year |
|---|---|
Involvement of the nitric oxide-cyclic GMP pathway in the desensitization of bradykinin responses of cultured rat sensory neurons.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Arginine; Binding, Competitive; Bradykinin; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Electric Conductivity; Ganglia, Spinal; Neurons, Afferent; Nitric Oxide; Nitroarginine; Nitroprusside; omega-N-Methylarginine; Rats | 1992 |
Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Arginine; Arteries; Bradykinin; Calcimycin; Coronary Vessels; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Nitroprusside; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Substance P; Thimerosal; Vasoconstrictor Agents | 1992 |
Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
Topics: Amino Acids; Animals; Arachidonic Acid; Arginine; Bradykinin; Cattle; Cells, Cultured; Chromatography, High Pressure Liquid; Endothelins; Endothelium, Vascular; Epoprostenol; Fluorescence; Nitric Oxide; omega-N-Methylarginine; Radioimmunoassay | 1992 |
Recovery of endothelium-dependent responses by reseeding endothelial cells in culture onto the denuded coronary artery.
Topics: Animals; Arginine; Bradykinin; Calcimycin; Cells, Cultured; Coronary Vessels; Endothelium, Vascular; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Serotonin; Swine; Vasodilator Agents | 1992 |
Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin.
Topics: Adenosine Diphosphate; Animals; Arginine; Bradykinin; Capillary Permeability; Cheek; Cricetinae; Male; Mesocricetus; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine | 1992 |
Intestinal lymphatic vessels release endothelial-dependent vasodilators.
Topics: Acetylcholine; Animals; Arginine; Arterioles; Bradykinin; Endothelium; Endothelium, Vascular; Ileum; Lymphatic System; Male; Muscle, Smooth; Muscle, Smooth, Vascular; omega-N-Methylarginine; Rats; Rats, Inbred Strains | 1992 |
Regulation of arteriolar tone and responses via L-arginine pathway in skeletal muscle.
Topics: Animals; Arginine; Arterioles; Bradykinin; Dose-Response Relationship, Drug; Indomethacin; Male; Muscles; Nitroarginine; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Vasomotor System | 1992 |
Inhibition in the rat of nitric oxide synthesis in vivo does not attenuate the hypotensive action of acetylcholine, ATP or bradykinin.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Arginine; Bradykinin; Endothelium, Vascular; Glyburide; Hypotension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains | 1992 |
A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts.
Topics: Animals; Arginine; Biological Assay; Bradykinin; Cell Line; Cyclic GMP; Fibroblasts; Lung; Nitric Oxide; omega-N-Methylarginine; Rats; Sensitivity and Specificity; Time Factors | 1991 |
Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Bradykinin; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; In Vitro Techniques; Methylene Blue; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Potassium; Prostaglandin Endoperoxides, Synthetic; Swine; Vasodilation | 1991 |
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Arginine; Arteriosclerosis; Bradykinin; Child; Child, Preschool; Coronary Vessels; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Humans; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Substance P; Vasoconstriction; Vasodilation | 1990 |
On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation.
Topics: Animals; Arginine; Bradykinin; Coronary Vessels; In Vitro Techniques; Molsidomine; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Oxyhemoglobins; Rabbits; Substance P; Trypsin; Vasodilation | 1991 |
Inhibition of nitric oxide, bradykinin, and prostaglandins in normal rats.
Topics: Animals; Arginine; Bradykinin; Hemodynamics; Indomethacin; Male; Nitric Oxide; omega-N-Methylarginine; Prostaglandin Antagonists; Rats; Rats, Inbred Strains; Regional Blood Flow | 1992 |
Endothelium-dependent vasodilation of canine coronary collateral vessels.
Topics: Acetylcholine; Animals; Arginine; Bradykinin; Collateral Circulation; Coronary Vessels; Dinoprost; Dogs; Endothelium, Vascular; Female; Male; omega-N-Methylarginine; Vasodilation | 1991 |
Effect of bradykinin antagonists, NG-monomethyl-L-arginine and L-NG-nitro arginine on phospholipase A2 induced oedema in rat paw.
Topics: Animals; Arginine; Bradykinin; Edema; Evans Blue; Foot; Kininogens; Male; Methysergide; Nitroarginine; omega-N-Methylarginine; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred Strains | 1991 |
Endothelium-derived relaxing factor: evidence that it regulates pulmonary vascular resistance in the isolated neonatal guinea pig lung.
Topics: Angiotensin II; Animals; Animals, Newborn; Arginine; Blood Pressure; Bradykinin; Guinea Pigs; In Vitro Techniques; Nitric Oxide; omega-N-Methylarginine; Pulmonary Circulation; Vascular Resistance | 1991 |
LTD4 and bradykinin evoke endothelium-dependent relaxation of the renal vein: dissimilar mechanisms.
Topics: Animals; Arginine; Benzopyrans; Bradykinin; Chromones; Cromakalim; Dogs; Endothelium, Vascular; Glyburide; Hemoglobins; Male; Methylene Blue; omega-N-Methylarginine; Pyrroles; Renal Veins; SRS-A; Vasodilation; Vasodilator Agents; Vasomotor System | 1991 |
Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin.
Topics: Animals; Arginine; Bradykinin; Diuresis; Dogs; Female; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Renal Circulation; Vasodilation | 1991 |
Effect of NG-monomethyl L-arginine on endothelium-dependent relaxation in arterioles of one-kidney, one clip hypertensive rats.
Topics: Acetylcholine; Animals; Arginine; Arterioles; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension, Renovascular; Male; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Vasodilation | 1991 |
Endothelium-derived and intraneuronal nitric oxide-dependent inhibition of norepinephrine efflux from sympathetic nerves by bradykinin.
Topics: Animals; Arginine; Bradykinin; Calcium; Canavanine; Dogs; Endothelium, Vascular; Female; Male; Neurons; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Physical Stimulation; Sympathetic Nervous System | 1991 |
Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension.
Topics: Acetylcholine; Animals; Arginine; Basilar Artery; Bradykinin; Chronic Disease; Endothelium, Vascular; Hypertension; Indomethacin; Male; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilation | 1990 |
Selective blockade of receptor-mediated cyclic GMP formation in N1E-115 neuroblastoma cells by an inhibitor of nitric oxide synthesis.
Topics: Animals; Arginine; Bradykinin; Carbachol; Cyclic GMP; Histamine; Mice; Neuroblastoma; Neurotensin; Nitric Oxide; omega-N-Methylarginine; Phosphatidylinositols; Receptors, Drug; Tumor Cells, Cultured | 1990 |
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.
Topics: Acetylcholine; Animals; Arginine; Bradykinin; Cattle; Cyclic GMP; Endothelium, Vascular; In Vitro Techniques; Kinetics; Muscle, Smooth, Vascular; omega-N-Methylarginine; Oxyhemoglobins; Phenylephrine; Pulmonary Artery; Pulmonary Veins; Vasoconstriction | 1990 |
NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
Topics: Adenosine Triphosphate; Animals; Arginine; Bradykinin; Calcimycin; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Melitten; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Pulmonary Artery | 1990 |
Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
Topics: Adenosine Diphosphate; Animals; Arginine; Bradykinin; Calcimycin; Cells, Cultured; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; In Vitro Techniques; Kinetics; Methylene Blue; Nitric Oxide; omega-N-Methylarginine; Oxyhemoglobins; Stimulation, Chemical; Superoxide Dismutase; Superoxides; Swine | 1990 |
Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation.
Topics: Acetylcholine; Animals; Arginine; Blood Pressure; Bradykinin; Endothelins; Epoprostenol; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Peptides; Rats; Stereoisomerism; Substance P | 1989 |
Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Angiotensin II; Animals; Arginine; Blood Pressure; Bradykinin; Hypoxia; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Pulmonary Artery; Rats; Rats, Inbred Strains; Stereoisomerism; Vasoconstriction | 1989 |
Nitric oxide release from porcine mitral valves.
Topics: Adenosine Diphosphate; Amino Acid Oxidoreductases; Animals; Arginine; Biological Assay; Bradykinin; Calcimycin; Calcium; Culture Techniques; Endocardium; Endothelium; Epithelium; Mitral Valve; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Substance P; Swine; Thrombin | 1993 |
A nitric oxide synthase inhibitor reduces desensitisation of bradykinin-induced activation of phospholipase C in sensory neurones.
Topics: Amino Acid Oxidoreductases; Animals; Animals, Newborn; Arginine; Bradykinin; Bucladesine; Cells, Cultured; Enzyme Activation; Ganglia, Spinal; Inositol Phosphates; Kinetics; Neurons, Afferent; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; omega-N-Methylarginine; Rats; Second Messenger Systems; Type C Phospholipases | 1993 |
Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Bradykinin; Hand; Humans; Male; Methylene Blue; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; Regional Blood Flow; Vascular Resistance; Vasodilation; Veins | 1994 |
Epicardial and endocardial coronary microvascular responses: effects of ischemia-reperfusion.
Topics: Adenosine; Animals; Arginine; Bradykinin; Calcimycin; Coronary Circulation; Endocardium; Endothelium, Vascular; Female; Glyburide; Guanylate Cyclase; Indomethacin; Male; Microcirculation; Muscle, Smooth, Vascular; Nitroprusside; omega-N-Methylarginine; Reperfusion Injury; Serotonin; Swine | 1994 |
Nitric oxide synthase inhibitors do not alter functional hyperemia in canine skeletal muscle.
Topics: Acetylcholine; Amino Acid Oxidoreductases; Animals; Arginine; Blood Flow Velocity; Bradykinin; Dogs; Endothelium; Female; Femoral Artery; Hyperemia; Male; Muscles; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Oxygen Consumption; Vasoconstriction | 1994 |
Nitric oxide and the cyclooxygenase pathway.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Bradykinin; Dinoprostone; Enzyme Induction; Escherichia coli; Guanidines; Hydronephrosis; Indomethacin; Inflammation; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Rabbits; Rats | 1995 |
Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Bradykinin; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Hydralazine; Male; Nitric Oxide; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Wistar; Vasodilation | 1995 |
Direct measurement of nitric oxide in human beings.
Topics: Acetylcholine; Adult; Arginine; Bradykinin; Dose-Response Relationship, Drug; Electrochemistry; Humans; Male; Nitric Oxide; omega-N-Methylarginine; Veins | 1995 |
Modulation of airway epithelial cell ciliary beat frequency by nitric oxide.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Bradykinin; Bronchi; Cattle; Cilia; Epithelium; In Vitro Techniques; Isomerism; Isoproterenol; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Substance P | 1993 |
Tumor necrosis factor inhibits stimulated but not basal release of nitric oxide.
Topics: Acetylcholine; Amino Acid Oxidoreductases; Animals; Arginine; Biological Assay; Bradykinin; Cattle; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Luminescent Measurements; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Tumor Necrosis Factor-alpha | 1993 |
Evidence for reduction of bradykinin-induced bronchoconstriction in guinea-pigs by release of nitric oxide.
Topics: Aerosols; Animals; Arginine; Blood Pressure; Bradykinin; Bronchoconstriction; Capillary Permeability; Capsaicin; Guinea Pigs; Hemodynamics; In Vitro Techniques; Injections, Intravenous; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Pulmonary Circulation; Vagotomy; Vascular Resistance | 1994 |
Bradykinin and capsaicin stimulate cyclic GMP production in cultured rat dorsal root ganglion neurons via a nitrosyl intermediate.
Topics: Animals; Arginine; Bradykinin; Bradykinin Receptor Antagonists; Calcium; Capsaicin; Cells, Cultured; Cyclic GMP; Ganglia, Spinal; Guanylate Cyclase; Methylene Blue; Neurons; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin | 1993 |
Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea.
Topics: Animals; Arginine; Bradykinin; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Female; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Methylene Blue; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Trachea | 1994 |
Selective loss of microvascular endothelial function in human hypercholesterolemia.
Topics: Acetylcholine; Adolescent; Adult; Aged; Arginine; Blood Vessels; Bradykinin; Endothelium, Vascular; Female; Forearm; Humans; Hypercholesterolemia; Male; Microcirculation; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vasodilation | 1994 |
Reduced endothelium-dependent vasodilation by acetylcholine and bradykinin in isolated nitroglycerin-tolerant blood vessels.
Topics: Acetylcholine; Animals; Arginine; Bradykinin; Drug Tolerance; Endothelium, Vascular; In Vitro Techniques; Kinetics; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; omega-N-Methylarginine; Pulmonary Artery; Swine; Vasodilation; Vasodilator Agents | 1994 |
EDRF in pulmonary resistance vessels from fetal lamb: stimulation by oxygen and bradykinin.
Topics: Animals; Arginine; Blood Vessels; Bradykinin; Indomethacin; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Oxygen; Pulmonary Circulation; Sheep; Vascular Resistance; Vasodilation | 1994 |
Bradykinin-induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine-sensitive kinase.
Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Aorta, Thoracic; Arginine; Bradykinin; Calcium; Cattle; Cell Line; Endothelium, Vascular; Epoprostenol; Ionomycin; Nitric Oxide; omega-N-Methylarginine; Phosphotransferases; Signal Transduction; Staurosporine | 1993 |
In vitro femoral arterial responses to vasoconstrictor and vasodilator agents in endotoxin shock.
Topics: Acetylcholine; Animals; Arginine; Arginine Vasopressin; Bradykinin; Femoral Artery; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Shock, Septic; Vasoconstrictor Agents; Vasodilator Agents | 1994 |
Ouabain enhances basal release of nitric oxide from carotid artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Bradykinin; Calcium; Carotid Arteries; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Ouabain; Prostaglandin Endoperoxides, Synthetic; Sodium-Potassium-Exchanging ATPase; Swine; Vasodilation | 1993 |
Pharmacological action of (-)-(2S,3aR,7aS)-1-[(S)-N-[(S)-1-carbonyl-3- phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arginine; Bradykinin; Enalaprilat; Endothelium, Vascular; Guinea Pigs; Ileum; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; omega-N-Methylarginine; Rats; Rats, Wistar | 1993 |
The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arginine; Bradykinin; Carotid Arteries; Cattle; Cells, Cultured; Cyclic GMP; Endothelins; Endothelium, Vascular; Epoprostenol; Female; Hemoglobins; Histamine; Humans; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pregnancy; Swine; Umbilical Veins | 1993 |
Neurogenic and non-neurogenic mechanisms of plasma extravasation in the rat.
Topics: Animals; Arginine; Blood Physiological Phenomena; Bradykinin; Dose-Response Relationship, Drug; Joints; Male; Models, Biological; omega-N-Methylarginine; Oxidopamine; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Time Factors | 1993 |
Mechanism of bradykinin-induced cyclic GMP accumulation in bovine tracheal smooth muscle.
Topics: Animals; Arginine; Bradykinin; Calcium; Cattle; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Immunohistochemistry; In Vitro Techniques; Methylene Blue; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Pyrogallol; Superoxide Dismutase; Trachea | 1995 |
The mechanisms of the renal effects of neutral endopeptidase inhibitor in rats.
Topics: Adrenergic beta-Antagonists; Animals; Arginine; Atrial Natriuretic Factor; Bradykinin; Cyclic GMP; Cyclohexanecarboxylic Acids; Kidney; Kinins; Male; Neprilysin; Nitric Oxide; omega-N-Methylarginine; Protease Inhibitors; Rats; Rats, Sprague-Dawley | 1995 |
Contribution of sustained Ca2+ elevation for nitric oxide production in endothelial cells and subsequent modulation of Ca2+ transient in vascular smooth muscle cells in coculture.
Topics: Animals; Aorta; Arginine; Bradykinin; Calcium; Calcium-Transporting ATPases; Cattle; Cells, Cultured; Chelating Agents; Coculture Techniques; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Indomethacin; Ionomycin; Kinetics; Muscle, Smooth, Vascular; Nickel; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Terpenes; Thapsigargin; Time Factors | 1996 |
Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide.
Topics: Adrenergic beta-Antagonists; Animals; Arginine; Bradykinin; Culture Techniques; Cyclic GMP; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelium; Guinea Pigs; Indomethacin; Isomerism; Male; Muscle Contraction; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Trachea | 1996 |
Nitric oxide modulation of Ca2+ responses in cow tracheal epithelium.
Topics: Adenosine Triphosphate; Animals; Arginine; Bradykinin; Calcium; Cattle; Epithelium; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Trachea | 1995 |
The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets.
Topics: Arginine; Bradykinin; Cells, Cultured; Endothelium, Vascular; Humans; Indomethacin; Methylmercury Compounds; Nitric Oxide; omega-N-Methylarginine; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Umbilical Arteries | 1995 |
The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice.
Topics: Animals; Bradykinin; Calcimycin; Carbachol; Cyanides; Hydralazine; Ionophores; Lethal Dose 50; Male; Mice; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Seizures; Substance P; Survival Rate | 1996 |
Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.
Topics: Adult; Albumins; Arginine; Bradykinin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Histamine; Histamine Antagonists; Humans; Male; Middle Aged; Nasal Cavity; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Vasoconstriction | 1996 |
Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs.
Topics: Analysis of Variance; Angiography; Animals; Arginine; Basilar Artery; Bradykinin; Citrulline; Cytokines; Dogs; Enzyme Inhibitors; Female; Injections, Spinal; Lipopolysaccharides; Male; Microscopy, Electron; Nitric Oxide Synthase; omega-N-Methylarginine; Subarachnoid Hemorrhage; Vasoconstrictor Agents; Vasodilation; Vasopressins | 1996 |
Nitric oxide as a chemical link in the generation of pain from veins in humans.
Topics: Bradykinin; Hand; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Osmolar Concentration; Pain; Sodium Chloride; Veins | 1996 |
Self-limiting enhancement by nitric oxide of oxygen free radical-induced endothelial cell injury: evidence against the dual action of NO as hydroxyl radical donor/scavenger.
Topics: Administration, Topical; Analysis of Variance; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Bradykinin; Cells, Cultured; Chelating Agents; Dimethyl Sulfoxide; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Free Radical Scavengers; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pentetic Acid; Swine | 1996 |
Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Enzyme Inhibitors; Hemodynamics; Hypertension; Imidazoles; Infusions, Intravenous; Kidney; Kinins; Losartan; Male; Meclofenamic Acid; Nitric Oxide; omega-N-Methylarginine; Prostaglandins; Pyridines; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Sodium; Tetrazoles | 1995 |
Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Dinoprostone; Dogs; Drug Interactions; Enzyme Inhibitors; Female; Hemodynamics; Indomethacin; Kidney; Nitric Oxide; omega-N-Methylarginine; Renal Circulation | 1997 |
Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Coronary Angiography; Coronary Disease; Coronary Vessels; Enalaprilat; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ultrasonography, Doppler; Ultrasonography, Interventional; Vasodilation | 1997 |
Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bradykinin; Coronary Vessels; Cyclooxygenase 1; Dogs; Enzyme Induction; Enzyme Inhibitors; Epoprostenol; In Vitro Techniques; Indans; Indomethacin; Isoenzymes; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Nitrobenzenes; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Up-Regulation | 1997 |
Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries.
Topics: Adrenergic alpha-Agonists; Animals; Bradykinin; Brimonidine Tartrate; Calcimycin; Cholesterol; Coronary Vessels; Endothelium, Vascular; Estradiol; Female; In Vitro Techniques; Indomethacin; Isometric Contraction; Lipoproteins; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Ovariectomy; Progesterone; Prostaglandins; Quinoxalines; Sex Characteristics; Sexual Maturation; Swine; Testosterone | 1997 |
Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis.
Topics: Adult; Aged; Bradykinin; Coronary Angiography; Coronary Circulation; Coronary Vessels; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Pericardium; Vascular Resistance; Vasodilation | 1997 |
Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arrhythmias, Cardiac; Bradykinin; Cardiac Output; Cardiac Surgical Procedures; Coronary Thrombosis; Coronary Vessels; Dinoprost; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Female; Infusions, Intravenous; Magnesium; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Pericardium; Platelet Aggregation Inhibitors; Postoperative Complications; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1998 |
Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Angiotensin II; Animals; Bradykinin; Cardiomegaly; Cells, Cultured; Coculture Techniques; Cyclic GMP; Endothelium, Vascular; Heart; Iloprost; Indomethacin; Male; Molsidomine; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Phenylalanine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley | 1998 |
Cellular pathways of mast cell- and capsaicin-sensitive nerve-evoked ileal submucosal arteriolar dilations.
Topics: Alprostadil; Animals; Arterioles; Bradykinin; Capsaicin; Cattle; Epoprostenol; Food Hypersensitivity; Guinea Pigs; Ileum; Indomethacin; Lactoglobulins; Mast Cells; Microscopy, Video; Milk; Muscle, Smooth; Neurons; omega-N-Methylarginine; Pyrilamine; Serotonin; Vasodilation | 1998 |
Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Airway Resistance; Animals; Asthma; Benzamides; Bradykinin; Bradykinin Receptor Antagonists; Bronchoconstriction; Citric Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Guinea Pigs; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Piperidines; Receptors, Neurokinin-2 | 1999 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
On the mechanism by which vascular endothelial cells regulate their oxygen consumption.
Topics: Animals; Aorta, Thoracic; Bradykinin; Calcium; Cells, Cultured; Egtazic Acid; Endothelium, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Oxygen Consumption; Swine | 1999 |
Bradykinin-induced bronchospasm in the rat in vivo: a role for nitric oxide modulation.
Topics: Airway Resistance; Animals; Bradykinin; Bradykinin Receptor Antagonists; Bronchial Provocation Tests; Bronchial Spasm; Bronchoconstrictor Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Lung Compliance; Male; Methacholine Chloride; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 1999 |
Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Chronic Disease; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Smoking; Vasodilation; Vasodilator Agents; Veins | 1999 |
Response of fetal rabbit ductus arteriosus to bradykinin: role of nitric oxide, prostaglandins, and bradykinin receptors.
Topics: Animals; Animals, Newborn; Bradykinin; Dinoprostone; Ductus Arteriosus; Endothelium, Vascular; Female; In Vitro Techniques; Isometric Contraction; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Pregnancy; Prostaglandins; Rabbits; Receptors, Bradykinin | 1999 |
Determinants of the response of human blood vessels to nitric oxide donors in vivo.
Topics: Adult; Bradykinin; Cyclic GMP; Dipyridamole; Forearm; Hand; Humans; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; omega-N-Methylarginine; Radial Artery; Vascular Resistance; Vasodilation; Veins | 1999 |
The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
Topics: Acetylcholine; Adenosine; Blood Flow Velocity; Bradykinin; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypercholesterolemia; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Vasodilation | 1999 |
Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS.
Topics: Adult; Arginine; Biopterins; Bradykinin; Endothelium, Vascular; Enzyme Inhibitors; Female; Gene Expression; Guanidines; Humans; Interleukin-1; Interleukin-6; Intracellular Signaling Peptides and Proteins; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; omega-N-Methylarginine; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Shock, Septic; Tumor Necrosis Factor-alpha; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Mechanisms of endothelium-dependent relaxation in myometrial resistance vessels and their alteration in preeclampsia.
Topics: Adult; Bradykinin; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Indomethacin; Myometrium; omega-N-Methylarginine; Pre-Eclampsia; Pregnancy; Vascular Resistance; Vasodilation | 1999 |
Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients.
Topics: Adaptation, Physiological; Adult; Antioxidants; Ascorbic Acid; Biological Availability; Bradykinin; Drug Combinations; Enzyme Inhibitors; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Ouabain; Reference Values; Vasodilation; Vasodilator Agents | 1999 |
Absence of nitrate tolerance after long-term treatment with ramipril: an endothelium-dependent mechanism.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Bradykinin; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Endothelium, Vascular; In Vitro Techniques; Losartan; Male; Nitrates; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Ramipril; Rats; Rats, Wistar; Superoxides; Time Factors; Vasodilator Agents | 1999 |
Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism.
Topics: Acetylcholine; Animals; Bradykinin; Coronary Vessels; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Female; Guanylate Cyclase; In Vitro Techniques; Male; Natriuretic Peptide, C-Type; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Polysaccharides; Receptors, Atrial Natriuretic Factor; Vasodilation | 1999 |
Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
Topics: Animals; Aorta; Body Water; Bradykinin; Capillary Permeability; Cattle; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Infant, Newborn; Lymphokines; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Penicillamine; Protein Kinase C; Retina; Serum Albumin; Staurosporine; Tetradecanoylphorbol Acetate; Thrombin; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Endothelium, Vascular; Guinea Pigs; Hypertrophy, Left Ventricular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Substance P; Vasodilator Agents | 2000 |
Autocrine action and its underlying mechanism of nitric oxide on intracellular Ca2+ homeostasis in vascular endothelial cells.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Bradykinin; Calcium; Calcium-Transporting ATPases; Cattle; Cells, Cultured; Endothelium, Vascular; Heparin; Homeostasis; Inositol 1,4,5-Trisphosphate; Molecular Sequence Data; Nitric Oxide; omega-N-Methylarginine; Transfection | 2000 |
Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization.
Topics: Adolescent; Adult; Brachial Artery; Bradykinin; Cyclooxygenase Inhibitors; Electrophysiology; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Potassium Channel Blockers; Serotonin; Tetraethylammonium; Vascular Resistance; Vasodilation | 2000 |
Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo.
Topics: Animals; Arterioles; Biological Factors; Bradykinin; Coronary Circulation; Coronary Vessels; Dogs; Endothelium, Vascular; Feedback; Indomethacin; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Vasodilation | 2000 |
Venous endothelial function in postmenopausal women who are receiving long-term estrogen and progestagen therapy.
Topics: Bradykinin; Endothelium, Vascular; Estrogens; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Middle Aged; Nitroprusside; omega-N-Methylarginine; Plethysmography; Postmenopause; Progestins; Vasodilator Agents; Veins | 2000 |
Integrative effects of nitric oxide and endothelium-derived hyperpolarizing factor induced by acetylcholine and bradykinin in rat hindquarter perfusion.
Topics: Acetylcholine; Animals; Aorta; Biological Factors; Blood Pressure; Bradykinin; Endothelium, Vascular; Femoral Artery; Hindlimb; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Rats; Rats, Wistar; Tetraethylammonium; Vasoconstriction; Vasodilation | 2000 |
[Vasodilator effects of bradykinin on the resistive circulation of the forearm of coronary patients].
Topics: Acetylcholine; Adult; Aged; Aspirin; Bradykinin; Coronary Disease; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; omega-N-Methylarginine; Platelet Aggregation Inhibitors; Reference Values; Regional Blood Flow; Vasodilation | 2000 |
Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans.
Topics: Acetylcholine; Adenosine; Arteriosclerosis; Bradykinin; Coronary Vessels; Female; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Bradykinin; Risk Factors; Vasomotor System | 2000 |
Postischemic anti-inflammatory effects of bradykinin preconditioning.
Topics: Animals; Anti-Inflammatory Agents; Bradykinin; Bradykinin Receptor Antagonists; Capillaries; Cell Adhesion; Chemotaxis, Leukocyte; Enzyme Inhibitors; Ischemic Preconditioning; Leukocytes; Male; Mesentery; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; omega-N-Methylarginine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2001 |
Myoglobin: A scavenger of bioactive NO.
Topics: Animals; Bradykinin; Coronary Circulation; Cytosol; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart; Isothiuronium; Magnetic Resonance Spectroscopy; Metmyoglobin; Mice; Mice, Knockout; Mitochondria, Heart; Models, Biological; Myocardial Contraction; Myocardium; Myoglobin; Nitrates; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxidation-Reduction; Vasodilation; Vasodilator Agents | 2001 |
Role of calcium-sensitive K(+) channels and nitric oxide in in vivo coronary vasodilation from enhanced perfusion pulsatility.
Topics: Acetylcholine; Animals; Apamin; Blood Flow Velocity; Bradykinin; Calcium; Charybdotoxin; Coronary Vessels; Dogs; Enzyme Inhibitors; Nitric Oxide; omega-N-Methylarginine; Peptides; Potassium; Potassium Channel Blockers; Potassium Channels; Pulsatile Flow; Signal Transduction; Vasodilation | 2001 |
Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
Topics: Animals; Antipain; Binding Sites; Biotinylation; Bradykinin; Cattle; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Humans; Kallikreins; Kinetics; Kininogen, High-Molecular-Weight; Lisinopril; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Prekallikrein; Pulmonary Artery; Receptors, Bradykinin; Serum Albumin, Bovine; Umbilical Arteries; Umbilical Veins; Zinc | 2001 |
The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide.
Topics: Allopurinol; Animals; Antibodies, Monoclonal; Antioxidants; Aorta; Ascorbic Acid; Aspirin; Bradykinin; Catecholamines; Cattle; Cells, Cultured; CHO Cells; Chromans; Cricetinae; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Flow Cytometry; Free Radical Scavengers; Hemostatics; Humans; Imidazolines; Lipoproteins, LDL; Mice; Nitric Oxide; omega-N-Methylarginine; Oxygen; Probucol; Protein Binding; Reactive Oxygen Species; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Superoxides; Thrombin; Time Factors | 2001 |
Changes in endothelium-dependent vasodilatation and alpha-adrenergic responses in resistance vessels during the menstrual cycle in healthy women.
Topics: Adrenergic alpha-Agonists; Adult; Blood Vessels; Bradykinin; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Menstrual Cycle; Middle Aged; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; omega-N-Methylarginine; Receptors, Adrenergic, alpha; Reference Values; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma.
Topics: Adult; Allergens; Asthma; Bradykinin; Bronchi; Female; Humans; Hypersensitivity, Immediate; Immunohistochemistry; Isoenzymes; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 2001 |
Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production.
Topics: Adenosine Diphosphate; Animals; Arginine; Bradykinin; Calcimycin; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen Peroxide; Hypochlorous Acid; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Oxidants; Swine | 2001 |
Nitric oxide modulates sympathoexcitatory cardiac-cardiovascular reflexes elicited by bradykinin.
Topics: Animals; Arginine; Baroreflex; Blood Pressure; Bradykinin; Cats; Denervation; Enzyme Inhibitors; Female; Heart Rate; Indazoles; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Sympathetic Nervous System; Vagotomy | 2001 |
Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Apolipoproteins E; Bradykinin; Cholesterol, LDL; Coronary Vessels; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Hypercholesterolemia; Iloprost; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Superoxide Dismutase; Vascular Resistance; Vasodilator Agents | 2002 |
The effects of hormone replacement therapy on endothelial function in women with Turner's syndrome.
Topics: Adult; Area Under Curve; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Estrogen Replacement Therapy; Female; Forearm; Humans; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; omega-N-Methylarginine; Regional Blood Flow; Turner Syndrome; Vasodilator Agents | 2002 |
Endothelial NO formation does not control myocardial O2 consumption in mouse heart.
Topics: Animals; Bradykinin; Coronary Circulation; Endothelium, Vascular; Enzyme Inhibitors; Heart; In Vitro Techniques; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oxygen Consumption; Vasodilation | 2003 |
Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro.
Topics: Acetylcholine; Animals; Bradykinin; Endothelium-Dependent Relaxing Factors; Histamine; In Vitro Techniques; Interleukin-1; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitroprusside; omega-N-Methylarginine; Phenylephrine; Rats; Rats, Wistar; Superoxides; Tumor Necrosis Factor-alpha | 2003 |
Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control.
Topics: Acetylcholine; Adult; Blood Glucose; Bradykinin; Cohort Studies; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Forearm; Humans; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Risk Factors; Sex Factors; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants.
Topics: Animals; Bothrops; Bradykinin; Carrageenan; Celecoxib; Crotalid Venoms; Heparin; Hindlimb; Histamine Antagonists; Hydroxyurea; Hyperalgesia; Male; omega-N-Methylarginine; Peptides; Phospholipases A; Pyrazoles; Rats; Rats, Wistar; Serotonin Antagonists; Sulfonamides; Time Factors | 2003 |
An AT1-receptor antagonist and an angiotensin-converting enzyme inhibitor protect against hypoxia-induced apoptosis in human aortic endothelial cells through upregulation of endothelial cell nitric oxide synthase activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Apoptosis; Benzimidazoles; Biphenyl Compounds; Bradykinin; Caspase 3; Caspases; Cell Hypoxia; Cells, Cultured; Endothelium, Vascular; Humans; Imidazoles; Necrosis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pyridines; Tetrazoles; Thiazepines | 2003 |
Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
Topics: Adult; Albuminuria; Area Under Curve; Bradykinin; Calcinosis; Coronary Artery Disease; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Risk Factors; Statistics as Topic; Vasodilator Agents; von Willebrand Factor | 2003 |
Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer.
Topics: Animals; Anti-Anxiety Agents; Aorta; Arginine; Bradykinin; Bradykinin B2 Receptor Antagonists; Capillary Permeability; Cells, Cultured; Cyclic AMP; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Indomethacin; Male; Neuropeptide Y; Nitric Oxide; omega-N-Methylarginine; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2004 |
Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS.
Topics: Acetylcholine; Adenoviridae; Animals; Bradykinin; Enzyme Inhibitors; Gene Expression; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Myocytes, Cardiac; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rabbits; Signal Transduction | 2004 |
Block of inward rectifying K+ channels (KIR) inhibits bradykinin-induced vasodilatation in human forearm resistance vasculature.
Topics: Acetylcholine; Adult; Albuterol; Brachial Artery; Bradykinin; Calcium Chloride; Cyclooxygenase Inhibitors; Drug Interactions; Forearm; Humans; Indomethacin; Male; Muscle, Smooth, Vascular; Norepinephrine; omega-N-Methylarginine; Ouabain; Plethysmography; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Sodium-Potassium-Exchanging ATPase; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Variations of endothelium-dependent vasoresponses in congestive heart failure.
Topics: Acetylcholine; Animals; Bradykinin; Coronary Vessels; Endothelium, Vascular; Heart Failure; Hemodynamics; In Vitro Techniques; Male; Muscle, Skeletal; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Inbred WKY; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Bradykinin down-regulates, whereas arginine analogs up-regulates, endothelial nitric-oxide synthase expression in coronary endothelial cells.
Topics: Arginine; Blotting, Western; Bradykinin; Cells, Cultured; Coronary Vessels; Down-Regulation; Endothelial Cells; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Up-Regulation | 2005 |
Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
Topics: Acetylcholine; Adult; Aryl Hydrocarbon Hydroxylases; Ascorbic Acid; Biological Factors; Bradykinin; Case-Control Studies; Cytochrome P-450 CYP2C9; Drug Combinations; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Hypertension; Male; Microcirculation; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Sulfaphenazole; Vasodilation; Vasodilator Agents | 2006 |
Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Bradykinin; Ciliary Arteries; Dogs; Electric Stimulation; Endothelium, Vascular; Enzyme Inhibitors; Myography; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Vasoconstrictor Agents; Vasodilation | 2007 |
IL-1beta-induced transcriptional up-regulation of bradykinin B1 and B2 receptors in murine airways.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Asthma; Bradykinin; Bronchial Hyperreactivity; Enzyme Inhibitors; Gene Expression Regulation; Humans; Infliximab; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred BALB C; Muscle Contraction; Muscle, Smooth; omega-N-Methylarginine; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Signal Transduction; Trachea; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2007 |
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Topics: Acetylcholine; Adult; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Bradykinin; Case-Control Studies; Cytochrome P-450 CYP2C9; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Male; Microcirculation; Middle Aged; omega-N-Methylarginine; Sulfaphenazole; Tissue Plasminogen Activator | 2009 |
Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
Topics: Adult; Aspirin; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Glucose; Humans; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Obesity; omega-N-Methylarginine; Regional Blood Flow; Tissue Plasminogen Activator; Vasodilation | 2010 |
Role of heme oxygenase in modulating endothelial function in mesenteric small resistance arteries of spontaneously hypertensive rats.
Topics: Acetylcholine; Animals; Bradykinin; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hypertension; Immunohistochemistry; In Vitro Techniques; Mesenteric Arteries; Metalloporphyrins; Nitric Oxide; omega-N-Methylarginine; Oxidative Stress; Protoporphyrins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Resistance; Vasodilation | 2009 |
Increased blood flow induces oxidative stress through an endothelium- and nitric oxide-independent mechanism.
Topics: Adult; Bradykinin; Calcium Channel Blockers; Diltiazem; Endothelium, Vascular; F2-Isoprostanes; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Oxidative Stress; Regional Blood Flow; Vasodilator Agents | 2010 |
Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fenoldopam; Imidazoles; Indomethacin; Kidney; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes; Vasodilation; Vasodilator Agents | 2013 |
Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites.
Topics: Acetylcholine; Adult; Biological Availability; Biological Factors; Black or African American; Bradykinin; Exercise; Female; Forearm; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Potassium Channels, Calcium-Activated; Tetraethylammonium Compounds; Vascular Resistance; Vasodilation; White People | 2014 |